Posted inBiotechnology
New Targeted Therapy Demonstrates Early Success Against KRAS-Driven Lung and Pancreatic Cancers
A groundbreaking first-in-human clinical trial has unveiled promising results for setidegrasib, an innovative therapeutic agent that specifically targets the KRAS…







